Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants-Reference-Cited by-同舟云学术

Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants

Published:2017-07-25 Issue:4 Volume:22 Page:1209-1216
ISSN:1090-7165
Container-title:AIDS and Behavior
language:en
Short-container-title:AIDS Behav

Author:

Meyers Kathrine,Rodriguez Kristina,Brill Atrina L.,Wu Yumeng,La Mar Melissa,Dunbar Debora,Koblin Beryl,Margolis David,Sobieszczyk Magdalena E.,Van Tieu Hong,Frank Ian,Markowitz Martin,Golub Sarit A.

Funder

National Institutes of Health

National Center for Advancing Translational Sciences

ViiV Healthcare

Penn Center for AIDS Research

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology

Link

http://link.springer.com/article/10.1007/s10461-017-1871-x/fulltext.html

Reference26 articles.

1. Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9.

2. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.

3. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet (London, England). 2016;387(10013):53–60.

4. Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, et al. Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med. 2016;176(1):75–84.

5. Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study;Journal of the Association of Nurses in AIDS Care;2024-08-13

2. Behind Prep Decisions: Understanding User Patterns and Discontinuation Factors in Real-World;AIDS and Behavior;2024-06-02

3. Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product design;Advanced Drug Delivery Reviews;2024-06

4. Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa: Quantitative and Qualitative Findings from HPTN 075;AIDS and Behavior;2024-05-18

5. Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition;Journal of the International AIDS Society;2023-07